Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), is expanding its biostorage footprint at Masy BioServices. Joining the company’s existing New England campus is a new 160,000 square foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C.

“As the preferred provider of cGMP storage, this expansion adds additional secure and dedicated cGMP space to meet client demand and represents the latest step in our strategic growth initiatives,” said Patrick Walsh, CEO, Alcami.

Located in Amherst, NH, the facility features state-of-the-art infrastructure and systems and will come online in three phases, with the first phase online this month with immediate capacity for over 7,000 pallets. Phase two is targeted to come online in the second half of 2022, which will double the capacity, with the remaining phase under review based on customer needs.

Masy BioServices, acquired by Alcami in December 2021, now operates four cGMP biostorage facilities near Boston, MA, offering secure and tightly controlled cGMP temperature storage from -135˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, pharmaceutical compounds and medical devices.

“We continue to expand across all Alcami service offerings and provide our customers reliable solutions for their clinical and commercial programs,” said Timothy Compton, chief business officer, Alcami.